- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£193.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£124.76
7D
5.7%
1Y
5.1%
Chugai Pharmaceutical
Market Cap: JP¥11.4t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥6,950.00
7D
1.5%
1Y
15.6%
Orion Oyj
Market Cap: €11.4b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€80.80
7D
3.1%
1Y
17.0%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥51.3b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥114.00
7D
-4.1%
1Y
19.8%
Xiamen Amoytop Biotech
Market Cap: CN¥24.4b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥59.77
7D
-0.6%
1Y
-28.9%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.1b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€60.50
7D
4.3%
1Y
5.8%
PharmaResearch
Market Cap: ₩4.3t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩414,500.00
7D
5.5%
1Y
-41.7%